Entrada Therapeutics (TRDA)

Entrada Therapeutics (TRDA) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• TRDA last traded at $4.54, 3.07% on the day.
• Entrada Therapeutics: P/E -1.3, revenue $4.69M over the last four quarters.
• Over the past year TRDA returned -34.28%; year to date -55.89%.

Updated 2026-11-03 00:43 UTC